Literature DB >> 1849052

Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver.

R C Cattley1, D S Marsman, J A Popp.   

Abstract

The carcinogenicity of the peroxisome proliferator WY-14,643 was compared in young (starting age 2 months) and old (starting age 15 months) rats. Old rats had a 5- to 7-fold higher yield of grossly visible hepatic tumors following 22 weeks of dietary WY-14,643 when compared to young rats. Volume densities of foci with large cells and homogeneously basophilic cytoplasm, cytologically similar to adenomas and carcinomas, were also higher in old rats fed WY-14,643 when compared to young rats. Although peroxisome proliferation and sustained hepatocellular proliferation have been suggested as relevant for the mechanism of WY-14,643 carcinogenicity, neither response was exaggerated in old versus young rats. Since initiation is considered to occur spontaneously and irreversibly, old rats may have a greater accumulation of spontaneously initiated hepatocytes than young rats. If so, these results are consistent with the hypothesis that the carcinogenic mechanism of the peroxisome proliferator WY-14,643 is due to the promotion of spontaneously initiated hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849052     DOI: 10.1093/carcin/12.3.469

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

1.  Juxtaposition of peroxisomes and chromosomes in mitotic hepatocytes following methyl clofenapate administration to rats.

Authors:  A R Soames; J R Foster
Journal:  Int J Exp Pathol       Date:  1994-12       Impact factor: 1.925

Review 2.  Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

Authors:  Ivan Rusyn; Jeffrey M Peters; Michael L Cunningham
Journal:  Crit Rev Toxicol       Date:  2006-05       Impact factor: 5.635

Review 3.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

4.  Transformation of mammalian cells by overexpressing H2O2-generating peroxisomal fatty acyl-CoA oxidase.

Authors:  S Chu; Q Huang; K Alvares; A V Yeldandi; M S Rao; J K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

5.  Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.

Authors:  Michael L Cunningham; Bradley J Collins; Milton R Hejtmancik; Ronald A Herbert; Gregory S Travlos; Molly K Vallant; Matthew D Stout
Journal:  PPAR Res       Date:  2010-10-04       Impact factor: 4.964

Review 6.  Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals.

Authors:  Gary Ginsberg; Dale Hattis; Abel Russ; Babasaheb Sonawane
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

Review 7.  Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?

Authors:  R L Melnick
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 8.  Biology of senescent liver peroxisomes: role in hepatocellular aging and disease.

Authors:  J Youssef; M Badr
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.